click below
click below
Normal Size Small Size show me how
Peptic Ulcers
USMLE Step 1
Drug | MOA & ADRs |
---|---|
Cimetidine | MOA: competitively - H2 receptors on parietal cells, 45 mins to work (taken 4 long term relief), also used 2 promote healing of ulcers & prevent future ulcers, used 2 tx GERD; ADRs: anti-androgenic -> gynecomastia, galactorrhea & decreased sperm count |
Ranitidine | MOA: competitively - H2 receptors on parietal cells, 45 mins to work (taken 4 long term relief), also used 2 promote healing of ulcers & prevent future ulcers, used 2 tx GERD |
Nizatidine | MOA: competitively - H2 receptors on parietal cells, 45 mins to work (taken 4 long term relief), also used 2 promote healing of ulcers & prevent future ulcers, used 2 tx GERD |
Famotidine | MOA: competitively - H2 receptors on parietal cells, 45 mins to work (taken 4 long term relief), also used 2 promote healing of ulcers & prevent future ulcers, used 2 tx GERD, most potent |
Misoprostol | MOA: analog of PGE2 works to decrease HCl secretion, often used to tx elderly pts who have been on long-term NSAID tx; ADRs: contraindicated in pregnancy due to cause uterine contractions, diarrhea, nausea |
Omeprazole | MOA: directly - the H+ pump, drug of choice for peptic ulcer; ADRs: increased gastric carcinoids from decreased HCl state & increased gastrin state, also indirectly increase gastric bacterial load |
Lansoprazole | MOA: directly - the H+ pump, drug of choice for peptic ulcer; ADRs: increased gastric carcinoids from decreased HCl state & increased gastrin state, also indirectly increase gastric bacterial load |
Pirenzepine | MOA: antimuscarinic act to - ACh effect H+ secretion, reserved for pts w/ Zollinger-Ellison or in pts 4 whom other txs failed, specific to M1 receptors (so affects stomach w/o affecting the heart, eye & salivary glands) |
Antacids | MOA: weak bases that form H2O and a salt when combined w/ HCl; ADRs: also affect other drugs that require a certain pH in order to be absorbed, pepsin is inactivated at pH > or = 7.4 |
CaCO3 | MOA: similar to antacid, but counter-protective b/c works through the Ca it provides to increase gastrin production; ADRs: Al & Mg containing prods cause constipation or diarrhea respectively |
NaHCO3 | MOA: antacid; ADRs: systemic alkalosis, increased CO2 prod yielding flatulence, belching & increased serum Na, thus contraindicated in pts w/ HPTN or CHF |
Sucralfate | MOA: mucosal protection, binds + charged grps in proteins of nml & necrotic mucosa, decrease inflammation & heal existing ulcers |
Bismuth | MOA: works to - pepsin, increasing mucus interaction w/ necrotic tissues (it coats and protects the crater), decrease inflammation, heal existing ulcers, also toxic to H. pylori, as well as many other types of bacteria |